Published in PLoS One on July 23, 2013
A Pneumococcal Protein Array as a Platform to Discover Serodiagnostic Antigens Against Infection. Mol Cell Proteomics (2015) 0.81
Identification of peptidoglycan-associated proteins as vaccine candidates for enterococcal infections. PLoS One (2014) 0.80
Data in support of proteomic analysis of pneumococcal pediatric clinical isolates to construct a protein array. Data Brief (2016) 0.75
A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology (1998) 17.05
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet (2009) 15.31
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis (2010) 8.37
Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev (1999) 7.76
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med (2006) 7.68
Serotype replacement in disease after pneumococcal vaccination. Lancet (2011) 7.14
Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun (1980) 5.90
Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis (2005) 3.72
Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens. Proc Natl Acad Sci U S A (2005) 3.59
Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax (2010) 3.34
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep (2012) 3.26
Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med (2010) 3.25
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome. Nat Biotechnol (2006) 3.03
Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect Immun (1994) 3.01
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun (2001) 2.68
Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J Infect Dis (1997) 2.50
Comparative efficacy of pneumococcal neuraminidase and pneumolysin as immunogens protective against Streptococcus pneumoniae. Microb Pathog (1988) 2.50
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50
T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe (2011) 2.30
Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun (2002) 2.15
Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med (2007) 2.11
Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Microb Pathog (1996) 1.91
Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS One (2010) 1.89
Streptococcus pneumoniae pilus subunits protect mice against lethal challenge. Infect Immun (2006) 1.74
Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block adhesion and protect mice against pneumococcal challenge. J Infect Dis (2008) 1.67
Clonal success of piliated penicillin nonsusceptible pneumococci. Proc Natl Acad Sci U S A (2007) 1.64
Clinical and economic burden of pneumococcal disease in older US adults. Vaccine (2010) 1.55
Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis. Infect Immun (2008) 1.54
Comparative efficacy of autolysin and pneumolysin as immunogens protecting mice against infection by Streptococcus pneumoniae. Microb Pathog (1992) 1.50
Pediatric parapneumonic empyema, Spain. Emerg Infect Dis (2008) 1.48
Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol (2004) 1.47
The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses. Infect Immun (2000) 1.28
Understanding the burden of pneumococcal disease in adults. Clin Microbiol Infect (2012) 1.24
Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun (2010) 1.22
The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease. Infect Immun (2004) 1.17
Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1. Mol Cell Proteomics (2009) 1.13
The streptococcal lipoprotein rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization. J Biol Chem (2005) 1.11
Pneumococcal vaccines for children: a global public health priority. Clin Microbiol Infect (2012) 1.09
Antibacterial vaccine design using genomics and proteomics. Trends Biotechnol (2001) 1.08
Improved accuracy of cell surface shaving proteomics in Staphylococcus aureus using a false-positive control. Proteomics (2010) 1.07
Profiling the surfacome of Staphylococcus aureus. Proteomics (2010) 1.07
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells. J Biol Chem (2010) 1.03
Two DHH subfamily 1 proteins contribute to pneumococcal virulence and confer protection against pneumococcal disease. Infect Immun (2011) 1.02
Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada. PLoS One (2011) 1.02
A proteomic analysis of penicillin resistance in Streptococcus pneumoniae reveals a novel role for PstS, a subunit of the phosphate ABC transporter. Mol Microbiol (2005) 0.97
Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae. Infect Immun (2006) 0.96
PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model. Infect Immun (2005) 0.95
A century of pneumococcal vaccination research in humans. Clin Microbiol Infect (2012) 0.95
Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306. PLoS One (2012) 0.92
The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J (2012) 0.92
Immunization with the iron uptake ABC transporter proteins PiaA and PiuA prevents respiratory infection with Streptococcus pneumoniae. Vaccine (2006) 0.92
Streptococcus pneumoniae: proteomics of surface proteins for vaccine development. Clin Microbiol Infect (2007) 0.91
Pneumonia immunization in older adults: review of vaccine effectiveness and strategies. Clin Interv Aging (2012) 0.90
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. Vaccine (2010) 0.89
Protective activity of Streptococcus pneumoniae Spr1875 protein fragments identified using a phage displayed genomic library. PLoS One (2012) 0.89
Another turn of the screw in shaving Gram-positive bacteria: Optimization of proteomics surface protein identification in Streptococcus pneumoniae. J Proteomics (2012) 0.88
Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence. PLoS One (2011) 0.87
Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies. PLoS One (2012) 0.86
Genomics and proteomics in reverse vaccines. Methods Biochem Anal (2006) 0.85
How effective is vaccination in preventing pneumococcal disease? Infect Dis Clin North Am (2013) 0.84
Overcoming function annotation errors in the Gram-positive pathogen Streptococcus suis by a proteomics-driven approach. BMC Genomics (2008) 0.84
Circulation of Streptococcus pneumoniae clone Colombia 5 ST289 in nine Latin American countries. Rev Panam Salud Publica (2009) 0.82
Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia. Clin Microbiol Infect (2011) 0.82
An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania. Pediatr Infect Dis J (2008) 0.82
Mucosal immunization with purified ClpP could elicit protective efficacy against pneumococcal pneumonia and sepsis in mice. Microbes Infect (2008) 0.81
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection. J Proteomics (2010) 0.81
The vaccine potential of Streptococcus pneumoniae surface lectin- and non-lectin proteins. Vaccine (2005) 0.81
Exploring the pan-surfome of Streptococcus suis: looking for common protein antigens. J Proteomics (2012) 0.80
Sortase A confers protection against Streptococcus pneumoniae in mice. Infect Immun (2009) 0.80
Proteomic analysis of membrane proteins from Streptococcus pneumoniae with multiple separation methods plus high accuracy mass spectrometry. OMICS (2011) 0.79
Analysis of cytoplasmic membrane proteome of Streptococcus pneumoniae by shotgun proteomic approach. J Microbiol (2011) 0.78
Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J (2011) 1.86
Association of human beta-defensin-2 serum levels and sepsis in preterm neonates*. Pediatr Crit Care Med (2013) 1.46
Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples. Pediatr Infect Dis J (2006) 1.16
Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1. Mol Cell Proteomics (2009) 1.13
Fourteen years of plant proteomics reflected in Proteomics: moving from model species and 2DE-based approaches to orphan species and gel-free platforms. Proteomics (2015) 1.11
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. Vaccine (2010) 0.89
Another turn of the screw in shaving Gram-positive bacteria: Optimization of proteomics surface protein identification in Streptococcus pneumoniae. J Proteomics (2012) 0.88
Successful management of chronic multifocal Q fever Osteomyelitis with adjuvant interferon-gamma therapy. Pediatr Infect Dis J (2011) 0.85
Risk factors associated with the antimicrobial resistance of staphylococci in canine pyoderma. Vet Microbiol (2011) 0.81
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection. J Proteomics (2010) 0.81
Exploring the pan-surfome of Streptococcus suis: looking for common protein antigens. J Proteomics (2012) 0.80
CYP1A-immunopositive proteins in bivalves identified as cytoskeletal and major vault proteins. Aquat Toxicol (2006) 0.80
Oxidative stress biomarkers in bivalves transplanted to the Guadalquivir estuary after Aznalcóllar spill. Environ Toxicol Chem (2003) 0.79
[Prudent use of antibiotics and suggestions for improvement from hospital-based medicine]. Enferm Infecc Microbiol Clin (2010) 0.78
Simplified human immunodeficiency virus maintenance therapy in virologically suppressed children with Ritonavir-boosted protease inhibitor monotherapy. Pediatr Infect Dis J (2011) 0.78
Atypical hemolytic uremic syndrome associated with Bordetella pertussis infection. Pediatr Infect Dis J (2012) 0.77
Decrease in drug resistance in pneumococcal community-acquired pneumonia. Chest (2007) 0.75
[Clinical and epidemiological features of pertussis among hospitalized infants in Seville during 2007-2011]. Enferm Infecc Microbiol Clin (2012) 0.75
[Deep vein thrombosis and septic pulmonary emboli associated with acute paediatric osteomyelitis due to methicillin-sensitive Staphylococcus aureus producing Panton-Valentine leukocidin]. Enferm Infecc Microbiol Clin (2011) 0.75
Comparison of two biochemical methods for identifying Corynebacterium pseudotuberculosis isolated from sheep and goats. Vet J (2013) 0.75
Stopping antiretroviral therapy in 'prematurely treated' HIV-1-infected children with full viral supression is safe. AIDS (2006) 0.75